tiprankstipranks
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market
2096
Simcere Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:2096 full AI Analyst Report?

Simcere Pharmaceutical Group Limited (2096) Financial Statements

4 Followers

Simcere Pharmaceutical Group Limited Financial Overview

Simcere Pharmaceutical Group Limited's market cap is currently HK$30.50B. The company's EPS TTM is HK$; its P/E ratio is 9.28; and it has a dividend yield of 1.36%. Simcere Pharmaceutical Group Limited is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 7.53B¥ 6.64B¥ 6.61B¥ 6.32B¥ 5.00B
Gross Profit¥ 6.15B¥ 5.32B¥ 4.98B¥ 5.00B¥ 3.92B
Operating Income¥ 1.22B¥ 848.05M¥ 711.80M¥ 862.50M¥ 1.45B
EBITDA¥ 1.60B¥ 1.35B¥ 1.08B¥ 815.38M¥ 422.45M
Net Income¥ 1.31B¥ 733.16M¥ 714.76M¥ 930.87M¥ 1.51B
Balance Sheet
Cash & Short-Term Investments¥ 3.62B¥ 1.94B¥ 2.02B¥ 2.62B¥ 2.18B
Total Assets¥ 14.73B¥ 11.51B¥ 10.85B¥ 10.78B¥ 10.16B
Total Debt¥ 1.20B¥ 1.21B¥ 1.43B¥ 1.51B¥ 1.64B
Net Debt¥ -2.35B¥ -733.70M¥ -577.94M¥ -150.86M¥ 662.74M
Total Liabilities¥ 5.31B¥ 4.44B¥ 3.63B¥ 3.64B¥ 3.70B
Stockholders' Equity¥ 9.41B¥ 7.07B¥ 7.22B¥ 7.13B¥ 6.44B
Cash Flow
Free Cash Flow¥ 1.15B¥ 628.54M¥ -828.81M¥ 676.71M¥ -411.46M
Operating Cash Flow¥ 2.01B¥ 1.39B¥ 151.05M¥ 1.35B¥ -201.97M
Investing Cash Flow¥ -1.33B¥ -1.05B¥ 1.09B¥ 68.31M¥ -435.50M
Financing Cash Flow¥ 894.39M¥ -407.40M¥ -894.83M¥ -753.68M¥ -1.62B
Currency in CNY

Simcere Pharmaceutical Group Limited Earnings and Revenue History

Income Statement >

Simcere Pharmaceutical Group Limited Debt to Assets

Balance Sheet >

Simcere Pharmaceutical Group Limited Cash Flow

Cash Flow >

Simcere Pharmaceutical Group Limited Forecast EPS vs Actual EPS

Earnings >